Grants
Grants listed represent those for which Johns Hopkins Infectious Diseases researchers are principal investigators.
Displaying 1 - 10 of 30 results
-
Long-Term Follow-up of an open-label single-arm phase IIb study of F901318
Research Grant Start Date:
12/02/2024Research Topics:
Research Lead Investigators:
-
A Multicenter, Randomized, Double-Blind, Placebo controlled Study to Assess the Efficacy and Safety of Treatment with Bepirovirsen in Participants living with Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection on Antiretroviral Treatment
Research Grant Start Date:
12/01/2024Research Topics:
Research Lead Investigators:
-
A5391: Doravirine for Persons with Excessive Weight Gain on Integrase Inhibitors and Tenofovir Alafenamide (The Do IT Study)
Research Grant Start Date:
11/27/2023Research Topics:
Research Lead Investigators:
-
Structured Peer-delivered ART and Reentry Community Strategy (SPARCS) to overcome barriers to HIV care continuity during community reentry from incarceration in South Africa
Research Grant Start Date:
09/01/2023Research Locations:
Research Topics:
Research Lead Investigators:
-
EVOLVE: Emetine for Viral Outbreaks, A Double Blind Randomized Controlled Clinical Trial
Research Grant Start Date:
06/01/2023Research Topics:
Research Lead Investigators:
-
Kidney Transplantation from Donors with HIV: Impact on Rejection and Long-term Outcomes
Research Grant Start Date:
05/25/2023Research Locations:
Research Topics:
Research Lead Investigators:
-
Olorofim for Invasive Fungal Infections PhIII
Research Grant Start Date:
01/03/2023Research Topics:
Research Lead Investigators:
-
AZD5156/AZD3152 mAbs for Covid-19 Prophylaxis in Immunocompromised Patients
Research Grant Start Date:
01/01/2023Research Locations:
Research Topics:
Research Lead Investigators:
-
A Phase 2 Study to Evaluate the Safety, Tolerability, and Efficacy of Regimens Containing VIR-2218, VIR-3434, and/or PEG-IFNa in Subjects with Chronic Hepatitis B Virus Infection
Research Grant Start Date:
12/02/2022Research Topics:
Research Lead Investigators:
-
Phase 3 Multicenter, Randomized, Double-Blind, Study to Assess the Efficacy and Safety of Treatment with Bepirovirsen in HBeAg-negative Nucleos(t)ide Analogue-treated Participants with Chronic Hepatit
Research Grant Start Date:
12/01/2022Research Topics:
Research Lead Investigators: